Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Natco Pharma
Natco Pharma
BSE: 524816NSE: NATCOPHARMISIN: INE987B01026

31st-Jul-2019 10:32Source: BSE

Natco Pharma - Board Meeting Intimation for To Consider Un-Audited Results For The Quarter Ended June 30, 2019 And Interim Dividend For The FY 19-20

NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve To consider un-audited results for the quarter ended June 30, 2019 and interim dividend for the FY 19-20

Sections
Follow us on
Available On
PCI DSS Compliant